Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: A pilot study

International Archives of Occupational and Environmental Health

Volumn 80, Issue 7, 2007, Pages 643-648

  Midasch, O ^a   Drexler, H ^a   Hart, N ^a   Beckmann, M W ^a   Angerer, J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Neonates; Perfluorooctanesulfonate (PFOS); Perfluorooctanoate(PFOA); Placental barrier; Umbilical cord blood

Indexed keywords

PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PLASMA PROTEIN;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD PLACENTA BARRIER; BLOOD SAMPLING; CONTROLLED STUDY; DECOMPOSITION; FEMALE; FETUS DEVELOPMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MATERNAL BLOOD; MATERNAL PLASMA; NEWBORN; PILOT STUDY; PRECIPITATION; PRENATAL EXPOSURE; UMBILICAL CORD BLOOD;

ADULT; ALKANESULFONIC ACIDS; FEMALE; FETAL BLOOD; FLUOROCARBONS; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; OCCUPATIONAL EXPOSURE; OCTANOIC ACIDS; PILOT PROJECTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

ANIMALIA;

EID: 34248176752     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00420-006-0165-9     Document Type: Article

References (46)

1. 3M (2002) 104-week dietary chronic toxicity and carcinogenicity study with perfluorooctane sulfonic acid potassium salt (PFOS; T-6295) in rats. Final Report. 3M T-6295 (Covance study no: 6329-183), vol I-IX, 4068 pages, 3M, St Paul, Minnesota
2. Butenhoff JL, Kennedy GL Jr, Frame SR, O'Connor JC, York RG (2004) The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196(1-2):95-116
3. Butenhoff JL, York R, Seacat A, Luebker D (2002) Perfluorooctanesulfonate induced perinatal mortality in rat pups is associated with a steep dose-response. Toxicologist 66:25
4. Calafat AM, Needham LL, Kuklenyik Z, Reidy JA, Tully JS, Aguilar-Villalobos M, Naeher LP (2005) Perfluorinated chemicals in selected residents of the American continent. Chemosphere 63(3):490-496
5. Christian MS, Hoberman AM, York RG (1999) Combined oral (gavage) fertility, developmental and perinatal/postnatal reproduction toxicity study of PFOS in rats. Argus Research Laboratories Inc., Horsham, PA US EPA Docket 8EHQ-0200-00374
6. Cochran TE, Good W (1974) The distribution of immunoglobulins and albumin between maternal and cord serum at delivery. J Obstet Gynaecol Br Commonw 81:980-987
7. Dinglasan MJ, Ye Y, Edwards EA, Mabury SA (2004) Fluorotelomer alcohol biodegradation yields poly- and perfluorinated acids. Environ Sci Technol 38(10):2857-2864
8. Ellis DA, Martin JW, De Silva AO, Mabury SA, Hurley MD, Sulbaek Andersen MP, Wallington TJ (2004) Degradation of fluorotelomer alcohols: A likely atmospheric source of perfluorinated carboxylic acids. Environ Sci Technol 38(12):3316-3321
9. Fromme H, Midasch O, Twardella D, Angerer J, Boehmer S, Liebl B (2006) Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Int Arch Occup Environ Health (in press)
10. Gauthier SA, Mabury SA (2005) Aqueous photolysis of 8:2 fluorotelomer alcohol. Environ Toxicol Chem 24(8):1837-1846
11. Giesy JP, Kannan K (2001) Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 35(7):1339-1342
12. Giesy JP, Kannan K (2002) Perfluorochemical surfactants in the environment. Environ Sci Technol 36(7):146A-152A
13. Grasty RC, Bjork JA, Wallace KB, Lau CS, Rogers JM (2005) Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res B Dev Reprod Toxicol 74(5):405-416
14. Grasty RC, Grey BE, Lau CS, Rogers JM (2003) Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B Dev Reprod Toxicol 68(6):465-471
15. Guruge KS, Taniyasu S, Yamashita N, Wijeratna S, Mohotti KM, Seneviratne HR, Kannan K, Yamanaka N, Miyazaki S (2005) Perfluorinated organic compounds in human blood serum and seminal plasma: A study of urban and rural tea worker populations in Sri Lanka. J Environ Monit 7(4):371-377
16. Han X, Snow TA, Kemper RA, Jepson GW (2003) Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 16(6):775-781
17. Harada K, Saito N, Inoue K, Yoshinaga T, Watanabe T, Sasaki S, Kamiyama S, Koizumi A (2004) The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years. J Occup Health 46(2):141-147
18. Hill MD, Abramson FP (1988) The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state. Clin Pharmacokinet 14(3):156-170
19. Hinderliter PM, Mylchreest E, Gannon SA, Butenhoff JL, Kennedy GL Jr (2005) Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats. Toxicology 211(1-2):139-148
20. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, Uno A, Saijo Y, Sata F, Yoshimura Y, Kishi R, Nakazawa H (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: Assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112(11):1204-1207
21. Jin Y, Liu X, Li T, Qin H (2004) Status of perfluorochemicals in adult serum and umbilical blood in Shenyang. Wei Sheng Yan Jiu 33(4):481-483
22. Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, Loganathan BG, Mohd MA, Olivero J, Van Wouwe N, Yang JH, Aldoust KM (2004) Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38(17):4489-4495
23. Kannan K, Koistinen J, Beckmen K, Evans T, Gorzelany JF, Hansen KJ, Jones PD, Helle E, Nyman M, Giesy JP (2001) Accumulation of perfluorooctane sulfonate in marine mammals. Environ Sci Technol 35(8):1593-1598
24. Kǎrrman A (2004) Perfluoroalkylated compounds in whole blood and plasma from the Swedish population. Organohalogen Compd 66:4058-4062
25. Krauer B, Dayer P, Anner R (1984) Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: An analysis of fetal-maternal pairs. Br J Obstet Gynaecol 91(9):875-881
26. Kubwabo C, Vais N, Benoit FM (2004) A pilot study on the determination of perfluorooctanesulfonate and other perfluorinated compounds in blood of Canadians. J Environ Monit 6(6):540-545
27. Kuklenyik Z, Reich JA, Tully JS, Needham LL, Calafat AM (2004) Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ Sci Technol 38(13):3698-3704
28. Lau C, Butenhoff JL, Rogers JM (2004) The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231-241
29. Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, Strynar MJ (2006) Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90(2):510-518
30. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 74(2):382-392
31. Luebker DJ, Case MT, York RG, Moore JA, Hansen KJ, Butenhoff JL (2005a) Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215(1-2):126-148
32. Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL (2005b) Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: Dose-response, and biochemical and pharamacokinetic parameters. Toxicology 215(1-2):149-169
33. Martin JW, Mabury SA, O'Brien PJ (2005) Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes. Chem Biol Interact 155(3):165-180
34. Midasch O, Schettgen T, Angerer J (2006) Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. Int J Hyg Environ Health 209(6):489-496
35. OECD (2002) Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts. ENV/JM/RD(2002)17/FINAL
36. Olsen G, Ehresman D, Froehlich J, Burris J, Butenhoff J (2005) Evaluation of the half-life (t1/2) of elimination of perfluorooctanesulfonate (PFOS), perfluorohexanesulfonate (PFHS) and perfluorooctanoate (PFOA) from human serum. Presentation at the 9th FLUOROS, International symposium on fluorinated alkyl organics in the environment, Toronto, Canada, Abstract book available at: http://www.chem.utoronto.ca/symposium/fluoros/Flourosabstractbook.pdf
37. Olsen GW, Church TR, Larson EB, van Belle G, Lundberg JK, Hansen KJ, Burris JM, Mandel JH, Zobel LR (2004) Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 54(11):1599-1611
38. Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O'Neill EM, Mandel JH, Zobel LR (2003a) Perfluorooctanesulfonate and other fluorochemicals in the serum of American red cross adult blood donors. Environ Health Perspect 111(16):1892-1901
39. Olsen GW, Hansen KJ, Stevenson LA, Burris JM, Mandel JH (2003b) Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. Environ Sci Technol 37(5):888-891
40. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 74(2):369-381
41. UBA (2004) Untersuchung archivierter Proben der Umweltprobenbank des Bundes auf perfluorierte organische Verbindungen. Cited in: http://www.bmu.de/files/chemikalien/downloads/application/pdf/ artikel_perfluortensiden.pdf
42. US EPA (2003) Preliminary risk assessment of the developmental toxicity associated with exposure to perfluorooctanoic acid and its salts. US EPA, OPPT-2003-0012; FRL-7303-8
43. US EPA (2005) Draft risk assessment of the potential human health effects associated with exposure to perfluorooctanoic acid and its salts. Available at http://www.epa.gov/opptintr/pfoa/pubs/pfoarisk.pdf
44. Wallington TJ, Hurley MD, Xia J, Wuebbles DJ, Sillman S, Ito A, Penner JE, Ellis DA, Martin J, Mabury SA, Nielsen OJ, Sulbaek Andersen MP (2006) Formation of C7F15COOH (PFOA) and other perfluorocarboxylic acids during the atmospheric oxidation of 8:2 fluorotelomer alcohol. Environ Sci Technol 40(3):924-930
45. Xu L, Krenitsky DM, Seacat AM, Butenhoff JL, Anders MW (2004) Biotransformation of N-ethyl-N-(2-hydroxyethyl) perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. Chem Res Toxicol 17(6):767-775
46. Yeung LW, So MK, Jiang G, Taniyasu S, Yamashita N, Song M, Wu Y, Li J, Giesy JP, Guruge KS, Lam PK (2006) Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China. Environ Sci Technol 40(3):715-720